Evidence map›Paper›PMID 36677908›Full record

ArticleMolecules (Basel, Switzerland)2023

Design and Synthesis of (

Jieun Lee, Yu Jung Park, Hee Jin Jung, Sultan Ullah, Dahye Yoon, Yeongmu Jeong, Ga Young Kim, Min Kyung Kang, Dongwan Kang, Yujin Park and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Design, synthesis,Heliyon · 2023
    Article
  6. Article
  7. Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances.International journal of molecular sciences · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jieun LeeLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Yu Jung ParkLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Hee Jin JungDepartment of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0001-7212-5572
Sultan UllahDepartment of Molecular Medicine, UF Scripps Biomedical Research, West Palm Beach, FL 33458, USA.
Dahye YoonLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Yeongmu JeongLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Ga Young KimLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Min Kyung KangLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
Dongwan KangDepartment of Medicinal Chemistry, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
Yujin ParkDepartment of Medicinal Chemistry, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
Pusoon ChunCollege of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Gyeongnam, Republic of Korea.
Hae Young ChungDepartment of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0002-3215-8828
Hyung Ryong MoonLaboratory of Medicinal Chemistry, Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.ORCID 0000-0003-1119-7112
Pusan National University · KRDaegu-Gyeongbuk Medical Innovation Foundation · KRInje University · KRScripps (United States) · US

Funding

National Research Foundation of Korea NRF-2020R1A2C1004198National Research Foundation of Korea NRF-2021R1I1A1A01052284
6 · The paper itself

Abstract

In this study, (

Indexed as

AntioxidantsEnzyme InhibitorsMelaninsMonophenol MonooxygenaseAntioxidantsEnzyme InhibitorsMelaninsMonophenol Monooxygenaseantioxidant activityBABTin silicoLineweaver–Burk plotsmelaninMITFtyrosinase

Identifiers

PMID36677908
PMCPMC9865752
OpenAlexW4316467904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.